TAPENTADOL (TAPENTADOL HYDROCHLORIDE) — all Canadian products
16 DINs
11 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is TAPENTADOL (TAPENTADOL HYDROCHLORIDE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02471965 | APO-TAPENTADOL | APOTEX INC | Tablet (Immediate-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 50 MG | Approved | |
| 02471981 | APO-TAPENTADOL | APOTEX INC | Tablet (Immediate-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 100 MG | Approved | |
| 02471973 | APO-TAPENTADOL | APOTEX INC | Tablet (Immediate-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 75 MG | Approved | |
| 02415577 | NUCYNTA EXTENDED-RELEASE | KNIGHT THERAPEUTICS INC. | Tablet (Extended-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 50 MG | Marketed | |
| 02415585 | NUCYNTA EXTENDED-RELEASE | KNIGHT THERAPEUTICS INC. | Tablet (Extended-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 100 MG | Marketed | |
| 02415593 | NUCYNTA EXTENDED-RELEASE | KNIGHT THERAPEUTICS INC. | Tablet (Extended-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 150 MG | Marketed | |
| 02415607 | NUCYNTA EXTENDED-RELEASE | KNIGHT THERAPEUTICS INC. | Tablet (Extended-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 200 MG | Marketed | |
| 02415615 | NUCYNTA EXTENDED-RELEASE | KNIGHT THERAPEUTICS INC. | Tablet (Extended-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 250 MG | Marketed | |
| 02378272 | NUCYNTA IR | KNIGHT THERAPEUTICS INC. | Tablet (Immediate-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 50 MG | Marketed | |
| 02378280 | NUCYNTA IR | KNIGHT THERAPEUTICS INC. | Tablet (Immediate-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 75 MG | Marketed | |
| 02378299 | NUCYNTA IR | KNIGHT THERAPEUTICS INC. | Tablet (Immediate-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 100 MG | Marketed | |
| 02360403 | NUCYNTA CR | JANSSEN INC | Tablet (Extended-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 150 MG | Cancelled Post Market | |
| 02360373 | NUCYNTA CR | JANSSEN INC | Tablet (Extended-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 50 MG | Cancelled Post Market | |
| 02360438 | NUCYNTA CR | JANSSEN INC | Tablet (Extended-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 250 MG | Cancelled Post Market | |
| 02360381 | NUCYNTA CR | JANSSEN INC | Tablet (Extended-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 100 MG | Cancelled Post Market | |
| 02360411 | NUCYNTA CR | JANSSEN INC | Tablet (Extended-Release) | Oral | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) 200 MG | Cancelled Post Market |
Browse other molecules: